Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinoma. Aoyama J, Nojima Y, Sano D, Hirai Y, et al. Head Neck 2023;45:1801-1811.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aoyama J, Nojima Y, Sano D, Hirai Y, et al. Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinoma. Head Neck 2023;45:1801-1811.
PMID: 37184432